Daniel Schneeberger
10% Owner at InMed Pharmaceuticals Inc. (INM); 10% Owner at Keros Therapeutics, Inc. (KROS); 10% Owner at Rallybio Corp (RLYB); 10% Owner at Tenax Therapeutics, Inc. (TENX)
Purchase track record
Market-like. Based on 3 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 16SEC | INMInMed Pharmaceuticals Inc. | Buy | 28,505829,505 held (+4%) | $1.29 | $37K | +5.4% |
| Sep 16SEC | INMInMed Pharmaceuticals Inc. | Buy | 54,256883,761 held (+7%) | $1.30 | $71K | +4.6% |
| Sep 16SEC | INMInMed Pharmaceuticals Inc. | Buy | 8,340892,101 held (+1%) | $1.29 | $11K | +5.4% |
| Sep 2SEC | TENXTenax Therapeutics, Inc. | Buy | 403,5715,257,389 held (+8%) | $1.79 | $722K | +4.5% |
| Sep 2SEC | TENXTenax Therapeutics, Inc. | Buy | 179,0585,436,447 held (+3%) | $1.80 | $322K | +3.9% |
| Sep 2SEC | TENXTenax Therapeutics, Inc. | Buy | 187,7045,624,151 held (+3%) | $1.80 | $338K | +3.9% |
| Aug 24SEC | TENXTenax Therapeutics, Inc. | Buy | 202,1244,030,075 held (+5%) | $1.78 | $360K | +5.1% |
| Aug 24SEC | TENXTenax Therapeutics, Inc. | Buy | 716,3694,746,444 held (+18%) | $1.77 | $1.3M | +5.6% |
| Aug 24SEC | TENXTenax Therapeutics, Inc. | Buy | 107,3744,853,818 held (+2%) | $1.75 | $188K | +6.9% |
| May 21SEC | INMInMed Pharmaceuticals Inc. | Buy | 68,551400,000 held (+21%) | $1.60 | $110K | -15.0% |
| May 21SEC | INMInMed Pharmaceuticals Inc. | Buy | 200,000600,000 held (+50%) | $1.56 | $312K | -12.8% |
| May 21SEC | INMInMed Pharmaceuticals Inc. | Buy | 200,000800,000 held (+33%) | $1.50 | $300K | -9.3% |
| May 15SEC | RLYBRallybio Corp | Buy | 4,081834,665 held (+0%) | $13.80 | $56K | +23.3% |
| May 15SEC | RLYBRallybio Corp | Buy | 75,178909,843 held (+9%) | $14.00 | $1.1M | +21.6% |
| May 15SEC | RLYBRallybio Corp | Buy | 100909,943 held (+0%) | $13.80 | $1K | +23.3% |
| May 15SEC | RLYBRallybio Corp | Buy | 200910,143 held (+0%) | $13.95 | $3K | +22.0% |
| May 6SEC | RLYBRallybio Corp | Buy | 3,900627,779 held (+1%) | $13.90 | $54K | +22.4% |
| May 6SEC | RLYBRallybio Corp | Buy | 116,904744,683 held (+19%) | $13.97 | $1.6M | +21.8% |
| May 6SEC | RLYBRallybio Corp | Buy | 35,101779,784 held (+5%) | $14.00 | $491K | +21.6% |
| Oct 15SEC | KROSKeros Therapeutics, Inc. | Sell | 4,391,237 | $17.75 | $77.9M | -32.7% |
| Oct 15SEC | KROSKeros Therapeutics, Inc. | Sell | 254,669 | $17.75 | $4.5M | -32.7% |
| Oct 15SEC | KROSKeros Therapeutics, Inc. | Sell | 743,358 | $17.75 | $13.2M | -32.7% |
- Buy
10% Owner Daniel Schneeberger bought $360K of TENX at $1.78 — first open-market purchase in our records.
- Buy
10% Owner Daniel Schneeberger bought $1.3M of TENX at $1.77 — largest purchase by this insider in our records.
- Buy
10% Owner Daniel Schneeberger bought $110K of INM at $1.60 — first open-market purchase in our records; raises the stake by 21%.
- Buy
10% Owner Daniel Schneeberger bought $312K of INM at $1.56 — largest purchase by this insider in our records; raises the stake by 50%.
- Buy
10% Owner Daniel Schneeberger bought $300K of INM at $1.50 — raises the stake by 33%.
- Buy
10% Owner Daniel Schneeberger bought $54K of RLYB at $13.90 — first open-market purchase in our records.